ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Signant Health brings its eConsent solution to China biospectrumasia
September 16, 2019The investigator-initiated schizophrenia focus trial, which will be the first Chinese study using Signant's TrialConsent solution, will involve hundreds of patients from multiple sites.
Pharma Sources Insight January 2025
